Screening for lung cancer--where are we now?
نویسنده
چکیده
Low-dose computed tomography (LDCT) screening has been shown to result in detection of earlier-stage lung cancers, with a 20% reduction in cancer-related deaths. LDCT screening offers significant potential benefits to selected patients; however, many questions remain, including questions about the applicability of lung cancer screening in clinical practice.
منابع مشابه
I-45: FISH and Array CGH for PGD of Cancer
We developed several FISH approaches to enable preimplantation genetic diagnosis of cancer predisposition syndromes. An overview of the applications and the results of those PGDs will be provided. In addition we developed several novel tools to genome wide screen for CNVs and SNPs in single cells. Those technologies are now being applied for polar body, blastomere and blastocyst screening for c...
متن کاملIdentification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning
Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...
متن کاملIdentification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning
Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...
متن کاملتخمین هزینه بهره وری غربالگری سرطان ریه در ایران توسط تصویر برداری سی تی اسکن دوز پایین با در نظر گرفتن تعداد تشخیص های زودهنگام
Introduction: Lung cancer is the most common and most deadly cancer in most of countries of the world. One of the most significant problems with this cancer is the lack of accurate and specific statistics about the prevalence and mortality rate in Iran. Results of cancer registry program in 2008 in Iran indicated a low incidence rate of lung cancer. However, these statistics...
متن کاملتخمین نرخ بروز استاندارد شده سنی سرطان ریه در ایران برای سال‌های 2014 و 2030
Introduction: lung cancer is the most deadly and the most expensive cancer all around the world. Limited studies have been conducted in the survey of incidence rate for lung cancer in IRAN. National report of cancer registry in IRAN (report 2008) indicates that mean value of ASR of lung cancer is 5.23 for men and women (7.09 for men and 3.38 for women). These values are so different from the va...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The American review of respiratory disease
دوره 130 4 شماره
صفحات -
تاریخ انتشار 1984